March 9, 2026 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against ARDT [Accessibility Statement] Skip NavigationNEW YORK, Feb. 11, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Ardent Health, Inc. ("Ardent Health, Inc." or the "Company") (NYSE: ARDT) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Ardent Health, Inc. investors who were adversely affected by alleged securities fraud between July 18, 2024 and November ...

Lost Money on Oracle Corporation(ORCL)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky [Accessibility Statement] Skip NavigationNEW YORK, Feb. 11, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Oracle Corporation ("Oracle" or the "Company") (NYSE: ORCL) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Oracle investors who were adversely affected by alleged securities fraud between June 12, 2025 and December 16, 2025 ...

Core Viewpoint - Varonis Systems, Inc. is facing a class action securities lawsuit due to alleged securities fraud that negatively impacted investors between February 4, 2025, and October 28, 2025 [1] Group 1: Lawsuit Details - The lawsuit claims that Varonis provided misleading statements about its ability to convert its customer base to its SaaS offering, which led to a significant reduction in annual recurring revenue (ARR) growth potential [1] - On October 28, 2025, Varonis reported third-quarter financial results that significantly missed ARR expectations and lowered its full-year guidance, attributing this to weaker than expected renewals and conversions in its subscription business [1] - Following the announcement, Varonis' stock price plummeted from $63.00 per share to $32.34 per share on October 29, 2025, marking a decline of approximately 48.67% in just one day [1] Group 2: Investor Actions - Investors who suffered losses during the specified timeframe have until March 9, 2026, to request appointment as lead plaintiff in the lawsuit [1] - Participation in the lawsuit does not require any out-of-pocket costs or fees for class members [1] Group 3: Legal Representation - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years [1] - The firm has been recognized as one of the top securities litigation firms in the United States for seven consecutive years [1]

Group 1 - The article discusses a class action securities lawsuit against Plug Power Inc. for alleged securities fraud occurring between January 17, 2025, and November 13, 2025 [1] - The lawsuit claims that Plug Power's management made false statements regarding the availability of funds from the U.S. Department of Energy's Loan Program and the company's ability to construct necessary hydrogen production facilities [1] - It is alleged that these misrepresentations led to a pivot towards less ambitious projects, impacting the company's commercial prospects [1] Group 2 - Investors affected by the alleged fraud have until April 3, 2026, to request to be appointed as lead plaintiff in the case [1] - Participation in the lawsuit does not require any out-of-pocket costs for class members, as compensation may be available without fees [1] - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years [1]

Core Viewpoint - A class action lawsuit has been filed against BellRing Brands, Inc. and its senior executives for securities fraud following a significant stock drop attributed to potential violations of federal securities laws [1][2]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the Southern District of New York, captioned Denha v. BellRing Brands, Inc., No. 1:26-cv-00575 [2]. - Investors have until March 23, 2026, to request to be appointed to lead the case [2]. Group 2: Company Background - BellRing Brands develops, markets, and sells "convenient nutrition" products, primarily ready-to-drink protein shakes under the Premier Protein brand [3]. - The company previously claimed that its sales growth was due to increased consumer demand and various positive factors, while downplaying competitive pressures [3]. Group 3: Stock Performance and Impact - On May 6, 2025, BellRing's CFO indicated that several key retailers had reduced their inventory levels, leading to a projected mid-single-digit headwind for Q3 growth, resulting in a stock price drop of $14.88 per share, or 19% [4]. - Following the announcement of narrowed fiscal year 2025 sales outlook on August 4, 2025, the stock dropped by $17.46 per share, nearly 33%, the next day [5][6].

NEW YORK, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that it has filed a class action lawsuit against Ardent Health, Inc. (NYSE:ARDT) and certain of the Company’s senior executives for securities fraud after a significant stock drop resulting from potential violations of the federal securities laws. If you invested in Ardent Health, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/ardent-health-inc-class-act ...

NEW YORK, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against CoreWeave, Inc. (NASDAQ:CRWV) and certain of the Company’s senior executives for securities fraud after significant stock drops resulting from the potential violations of the federal securities laws. If you invested in CoreWeave, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/coreweave-inc-class-action-l ...

Core Viewpoint - A class action lawsuit has been filed against Plug Power Inc. and certain senior executives for securities fraud following significant stock drops attributed to potential violations of federal securities laws [1][3]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the Northern District of New York, captioned Ortolani v. Plug Power Inc., et al., No. 1:26-cv-00165 [3]. - Investors have until April 3, 2026, to request to be appointed to lead the case [3]. - The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Plug Power securities [3]. Group 2: Company Background - Plug Power provides hydrogen fuel cell turnkey solutions for electric mobility and stationary power markets and develops infrastructure such as hydrogen production plants [4]. - The company announced a "closed a $1.66 billion loan guarantee" from the U.S. Department of Energy to finance the construction of hydrogen production projects [4]. Group 3: Stock Performance and Events - On October 7, 2025, Plug Power's stock dropped by $0.26 per share (6.3%) following the abrupt departure of CEO Andrew Marsh and President Sanjay Shrestha, from $4.13 to $3.87 per share [5]. - On November 10, 2025, the company announced the suspension of activities under the DOE loan program, leading to a stock drop of $0.09 per share (3.4%), from $2.65 to $2.56 per share [6]. - On November 13, 2025, it was reported that Plug Power confirmed the suspension of plans to construct hydrogen production facilities, resulting in a stock drop of $0.48 per share (17.6%), from $2.49 to $2.25 per share [7].

Core Viewpoint - Varonis Systems, Inc. is facing a securities class action lawsuit due to allegations of misleading investors about its transition to a Software-as-a-Service (SaaS) model, which resulted in significant financial losses for shareholders [1]. Company Performance - The lawsuit claims that Varonis executives misrepresented the company's ability to convert its legacy on-premise customer base to its new SaaS platform, leading to a 63.9% year-over-year decline in term license subscription revenues disclosed on October 28, 2025 [1]. - Following this disclosure, Varonis's stock price plummeted by 48%, dropping from $63.00 to $32.34, resulting in a loss of approximately $3.8 billion in market capitalization [1]. Allegations of Misleading Statements - The litigation alleges that Varonis provided false assurances regarding its SaaS transition, claiming it was "well on our way to becoming a SaaS company" and that it would "accelerate [its] SaaS transition" [1]. - The company reportedly misrepresented its conversion potential, stating that it had a "massive opportunity to increase the ARR from our existing customer base," while the reality indicated a struggle to convince on-premises users to migrate [1]. Financial Guidance and Performance Issues - Following a disappointing Q3 performance, Varonis significantly reduced its Q4 revenue and full-year annual recurring revenue (ARR) guidance [1]. - The lawsuit highlights that weaker renewals in both the Federal vertical and non-Federal on-prem subscription business contributed to the company's performance miss, contradicting previous optimistic statements from Varonis [1].

Core Viewpoint - A class action lawsuit has been filed against Inovio Pharmaceuticals, Inc. for alleged securities fraud, with investors who purchased shares between October 10, 2023, and December 26, 2025, potentially entitled to compensation [1]. Group 1: Lawsuit Details - The lawsuit claims that Inovio made false and misleading statements regarding its CELLECTRA device manufacturing and the likelihood of submitting the INO-3107 Biologics License Application (BLA) to the FDA by the second half of 2024 [1]. - It is alleged that Inovio lacked sufficient information to justify the INO-3107 BLA's eligibility for FDA accelerated approval or priority review, leading to overstated regulatory and commercial prospects [1]. - The lawsuit asserts that when the true details were revealed, investors suffered damages due to the misleading public statements made by the defendants [1]. Group 2: Legal Representation - The Rosen Law Firm, which is leading the class action, emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [1]. - The firm has a history of significant recoveries for investors, including over $438 million in 2019 alone, and has been recognized for its achievements in securities class action settlements [1]. - Investors interested in joining the class action can do so without upfront fees through a contingency fee arrangement [1].